PRODUCT DEVELOPMENT

In response to the health needs of the population, we capture information, analyze and produce the best medicines to generate well-being.

Development
Identification of the medical condition that is intended to attack or improve the established treatment. The first tests are carried out to identify safety, tolerance and dosage elements. The work done can lead to a patent application.
Clinical
The product is tested in different studies, the first is pharmacokinetic studies (effects of the organism on the drug), the second is on the dose of the drug and the third is to establish the efficacy of the product. This phase is performed in large groups of people.
Registration
As the name suggests, this stage encloses the drug product or medical device registration before the corresponding regulatory agencies for distribution. Our drug product development plan includes a risk identification stage and the development of a risk-reduction strategy.

We work on the continuous improvement of developments and patents

Committed to the development of new dosage forms and the creation or improvement of medical devices, we offer high-value competitive advantages in competitive and niche markets.

We have various lines of pharmaceutical products with the highest quality controls, which are classified as:

  • High blood pressure and metabolic syndrome
  • Anti-TB agents
  • Vitamins
  • Pain medication
  • Deworming drugs
  • Drugs for the prevention of asthma and other similar conditions

Line of GENERIC DRUGS:
We developed a quality alternative for the prescription of various drugs such as captopril, carbamazepine, lysine clonixinate, enalapril, among others.

BIOTECHNOLOGICAL PRODUCTS line:
They are products based on antibodies and therapeutic peptides, aimed at the treatment of ocular, inflammatory, neurodegenerative diseases, autoimmune disorders, infectious diseases and diabetes.

Silanes invests in infrastructure and technology, responding to the growing demand for products that respond to real health needs, achieving optimal levels of quality to obtain the maximum benefit from the medicines developed.

Patents

Granted / Valid
11
National Patents
99
Foreign Patents
311
National proprietary brands
300
Foreign proprietary brands
Requested
8
National Patents
69
Foreign Patents
14
National proprietary brands
5
Foreign proprietary brands